GGrantIndex
← Leaderboards

Karen L. Furie

Massachusetts General Hospital

Google Scholar ↗PubMed ↗ORCID ↗
$5,939,373
Attributed
$8,396,137
Total exposure
14
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,256,170 · 14
AHRQ$0 · 1

By mechanism

P50$14,377,584 · 4
U24$2,564,903 · 1
R01$1,344,625 · 2
K23$851,992 · 1
M01$737,881 · 5
R21$279,185 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Stroke”

Research focus

StrokeClinical ResearchProgramsTranslational ResearchAcuteAcute StrokeFutureClinical TrialsInternationalHuman SubjectResearch PersonnelInfarctionCommunitiesScienceHospitalsDesignFundingResearch Project GrantsPatient Oriented ResearchMonitorEnrollmentMemberNational Institute Of Neurological Disorders And StrokeCollaborations

Grant awards (54)

Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$399,587
U24 · FY2025 · NS
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$494,611
U24 · FY2024 · NS
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$327,391
U24 · FY2022 · NS
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$327,391
U24 · FY2021 · NS
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$327,391
U24 · FY2020 · NS
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$327,391
U24 · FY2019 · NS
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$361,141
U24 · FY2018 · NS
CHADSS: Chagas Disease Scan Study$53,083
R01 · FY2015 · NS
CHADSS: Chagas Disease Scan Study$322,098
R01 · FY2014 · NS
CHADSS: Chagas Disease Scan Study$311,909
R01 · FY2013 · NS
Blood and Tissue$132,438
P50 · FY2013 · NS · contact PI
CHADSS: Chagas Disease Scan Study$328,494
R01 · FY2012 · NS
Blood and Tissue$79,537
P50 · FY2012 · NS · contact PI
Specialized Program of Translational Research in Acute Stroke- Project 1$1,615,536
P50 · FY2011 · NS · contact PI
Specialized Programs of Translational Research in Acute Stroke at the Partners$1,215,479
P50 · FY2011 · NS · contact PI
CHADSS: Chagas Disease Scan Study$329,041
R01 · FY2011 · NS
Blood and Tissue$78,649
P50 · FY2011 · NS · contact PI
Specialized Programs of Translational Research in Acute Stroke at the Partners$2,582,989
P50 · FY2010 · NS · contact PI
27th Princeton Conference on Cerebrovascular Diseases$100,000
R13 · FY2010 · NS · contact PI
Blood and Tissue$78,252
P50 · FY2010 · NS · contact PI
Specialized Program of Translational Research In Acute Stroke at the Partners$1,543,549
P50 · FY2009 · NS · contact PI
Specialized Program of Translational Research in Acute Stroke at the Partners Hea$257,259
P50 · FY2009 · NS · contact PI
Oxidative Stress and MMP's$257,257
P50 · FY2009 · NS · contact PI
Specialized Program of Translational Research In Acute Stroke at the Partners$1,583,315
P50 · FY2008 · NS · contact PI
Oxidative Stress and MMP's$263,886
P50 · FY2008 · NS · contact PI
Specialized Program of Translational Research in Acute Stroke at the Partners Hea$263,886
P50 · FY2008 · NS · contact PI
CLINICAL TRIAL: PARTNERS SPECIALIZED PROGRAM OF TRANSLATIONAL RESEARCH IN ACUTE$42,091
M01 · FY2008 · RR · contact PI
Specialized Program of Translational Research In Acute Stroke at the Partners$1,636,482
P50 · FY2007 · NS · contact PI
Specialized Program of Translational Research in Acute Stroke at the Partners Hea$272,748
P50 · FY2007 · NS · contact PI
Oxidative Stress and MMP's$272,747
P50 · FY2007 · NS · contact PI
Specialized Program of Translational Research In Acute Stroke at the Partners$1,682,683
P50 · FY2006 · NS · contact PI
Oxidative Stress and MMP's$280,446
P50 · FY2006 · NS · contact PI
Specialized Program of Translational Research in Acute Stroke at the Partners Hea$280,446
P50 · FY2006 · NS · contact PI
Genetic Markers of Thrombosis in Embolic Stroke$170,676
K23 · FY2006 · NS · contact PI
Genetic Markers of Thrombosis in Embolic Stroke$170,578
K23 · FY2005 · NS
GENES AFFECTING STROKE RISK AND OUTCOMES STUDY (GASROS)$17,213
M01 · FY2005 · RR
THE BIOMARKER EVALUATIONS FOR ANTIOXIDANT THERAPIES IN STROKE (BEAT STROKE)$478
M01 · FY2005 · RR
Screening Technology and Outcomes Project in Stroke$0
R01 · FY2005 · HS
Genetic Markers of Thrombosis in Embolic Stroke$170,455
K23 · FY2004 · NS
Assessment of Stroke Risk and Outcome in Chagas Disease$113,209
R21 · FY2004 · NS
Assessment of Stroke Risk and Outcome in Chagas Disease$50,000
R21 · FY2004 · NS
GENES AFFECTING STROKE RISK AND OUTCOMES STUDY (GASROS)$42,587
M01 · FY2004 · RR
THE BIOMARKER EVALUATIONS FOR ANTIOXIDANT THERAPIES IN STROKE (BEAT STROKE)$24,336
M01 · FY2004 · RR
VITAMIN INTERVENTION FOR STROKE PREVENTION (VISP)$7,744
M01 · FY2004 · RR
WARFARIN VS ASPIRIN REDUCED CARDIAC EJECTION FRACTION (WARCEF) STUDY$553
M01 · FY2004 · RR
Genetic Markers of Thrombosis in Embolic Stroke$169,905
K23 · FY2003 · NS
Assessment of Stroke Risk and Outcome in Chagas Disease$115,976
R21 · FY2003 · NS
VITAMIN INTERVENTION FOR STROKE PREVENTION (VISP)$200,768
M01 · FY2002 · RR
VITAMIN INTERVENTION FOR STROKE PREVENTION (VISP)$200,768
M01 · FY2002 · RR
Genetic Markers of Thrombosis in Embolic Stroke$170,378
K23 · FY2002 · NS
VITAMIN INTERVENTION FOR STROKE PREVENTION (VISP)$200,768
M01 · FY2001 · RR
VITAMIN INTERVENTION FOR STROKE PREVENTION (VISP)$0
M01 · FY2001 · RR
VITAMIN INTERVENTION FOR STROKE PREVENTION (VISP)$575
M01 · FY2000 · RR
VITAMIN INTERVENTION FOR STROKE PREVENTION (VISP)$0
M01 · FY2000 · RR